Oric Pharmaceuticals Inc (ORIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 142,895 | 110,780 | 91,767 | 78,871 | 74,186 |
| Operating Income | -142,895 | -110,780 | -91,767 | -78,871 | -74,186 |
| Other Income | 15,048 | 10,083 | 2,645 | 156 | 483 |
| Pre-tax Income | -127,847 | -100,697 | -89,122 | -78,715 | -73,703 |
| Net Income Continuous | -127,847 | -100,697 | -89,122 | -78,715 | -73,703 |
| Net Income | $-127,847 | $-100,697 | $-89,122 | $-78,715 | $-73,703 |
| EPS Basic Total Ops | -1.83 | -1.96 | -2.25 | -2.07 | -3.36 |
| EPS Basic Continuous Ops | -1.83 | -1.96 | -2.25 | -2.07 | -3.36 |
| EPS Diluted Total Ops | -1.83 | -1.96 | -2.25 | -2.07 | -3.36 |
| EPS Diluted Continuous Ops | -1.83 | -1.96 | -2.25 | -2.07 | -3.36 |
| EPS Diluted Before Non-Recurring Items | -1.83 | -1.96 | -2.25 | -2.07 | -3.36 |
| EBITDA(a) | $-149,891 | $-115,917 | $-91,843 | $-76,625 | $-72,917 |